Bank of Nanjing Valuation
Is 601009 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Unter dem Marktwert
Deutlich unter dem Marktwert
Price-To-Earnings gegen Gleichaltrige
Price-To-Earnings gegen Industrie
PM vs. Fair Ratio
Analysten-Prognose
Share Price vs Fair Value
What is the Fair Price of 601009 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Unter dem Marktwert: 601009 (CN¥7.28) wird unter unserer Schätzung des Fair Value (CN¥22.89) gehandelt.
Deutlich unter dem Marktwert: 601009 wird um mehr als 20 % unter dem Marktwert gehandelt.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 601009?
Other financial metrics that can be useful for relative valuation.
What is 601009's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | CN¥94.13b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | n/a |
Enterprise Value/EBITDA | n/a |
PEG Ratio | 0.5x |
Price to Earnings Ratio vs Peers
How does 601009's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 5.1x | ||
002142 Bank of Ningbo | 5.5x | 12.1% | CN¥139.9b |
600926 Bank of Hangzhou | 5.1x | 17.6% | CN¥67.1b |
600919 Bank of Jiangsu | 5.1x | 17.7% | CN¥145.3b |
601838 Bank of Chengdu | 4.7x | 16.4% | CN¥52.5b |
601009 Bank of Nanjing | 5.1x | 10.0% | CN¥94.1b |
Price-To-Earnings gegen Gleichaltrige: 601009 ist auf der Grundlage des Price-To-Earnings Verhältnisses (5.1x) im Vergleich zum Durchschnitt der Vergleichsgruppe (5.1x) teuer.
Price to Earnings Ratio vs Industry
How does 601009's PE Ratio compare vs other companies in the CN Banks Industry?
Price-To-Earnings gegen Industrie: 601009 ist aufgrund seines Price-To-Earnings Verhältnisses (5.1x) im Vergleich zum CN Banks Branchendurchschnitt (5.2x) ein guter Wert.
Price to Earnings Ratio vs Fair Ratio
What is 601009's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 5.1x |
Fair PE Ratio | 5.1x |
PM vs. Fair Ratio: 601009 ist teuer auf der Grundlage des Verhältnisses Price-To-Earnings (5.1x) im Vergleich zum geschätzten fairen Verhältnis Price-To-Earnings (5.1x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | CN¥9.10 | CN¥9.17 +0.7% | 15.3% | CN¥12.18 | CN¥7.00 | n/a | 13 |
Mar ’25 | CN¥8.71 | CN¥9.10 +4.5% | 15.9% | CN¥12.18 | CN¥7.00 | n/a | 13 |
Feb ’25 | CN¥8.26 | CN¥9.10 +10.2% | 15.9% | CN¥12.18 | CN¥7.00 | n/a | 13 |
Jan ’25 | CN¥7.38 | CN¥9.53 +29.1% | 17.2% | CN¥12.18 | CN¥7.00 | n/a | 13 |
Dec ’24 | CN¥7.28 | CN¥9.77 +34.3% | 13.8% | CN¥12.18 | CN¥7.49 | n/a | 13 |
Nov ’24 | CN¥7.78 | CN¥9.78 +25.7% | 13.7% | CN¥12.18 | CN¥7.56 | n/a | 13 |
Oct ’24 | CN¥8.05 | CN¥10.79 +34.1% | 16.1% | CN¥12.91 | CN¥8.40 | n/a | 12 |
Sep ’24 | CN¥7.95 | CN¥11.52 +44.9% | 20.0% | CN¥17.50 | CN¥8.46 | n/a | 13 |
Aug ’24 | CN¥8.57 | CN¥11.73 +36.9% | 19.8% | CN¥17.50 | CN¥8.60 | n/a | 13 |
Jul ’24 | CN¥8.00 | CN¥11.90 +48.7% | 18.7% | CN¥17.50 | CN¥8.60 | n/a | 13 |
Jun ’24 | CN¥8.46 | CN¥13.22 +56.3% | 14.4% | CN¥17.50 | CN¥9.98 | n/a | 14 |
May ’24 | CN¥9.42 | CN¥13.69 +45.3% | 13.7% | CN¥17.50 | CN¥9.98 | n/a | 13 |
Apr ’24 | CN¥8.96 | CN¥14.16 +58.1% | 13.2% | CN¥17.50 | CN¥9.98 | CN¥9.09 | 12 |
Mar ’24 | CN¥9.94 | CN¥14.15 +42.4% | 12.7% | CN¥17.50 | CN¥9.97 | CN¥8.71 | 13 |
Feb ’24 | CN¥10.40 | CN¥14.15 +36.1% | 12.7% | CN¥17.50 | CN¥9.97 | CN¥8.26 | 13 |
Jan ’24 | CN¥10.42 | CN¥13.95 +33.8% | 13.5% | CN¥17.50 | CN¥9.97 | CN¥7.38 | 13 |
Dec ’23 | CN¥10.18 | CN¥13.93 +36.8% | 13.8% | CN¥17.50 | CN¥9.72 | CN¥7.28 | 13 |
Nov ’23 | CN¥10.34 | CN¥13.93 +34.7% | 13.8% | CN¥17.50 | CN¥9.72 | CN¥7.78 | 13 |
Oct ’23 | CN¥10.52 | CN¥13.79 +31.1% | 13.0% | CN¥17.50 | CN¥9.86 | CN¥8.05 | 13 |
Sep ’23 | CN¥10.56 | CN¥13.91 +31.7% | 13.4% | CN¥17.50 | CN¥9.86 | CN¥7.95 | 12 |
Aug ’23 | CN¥10.38 | CN¥14.17 +36.5% | 13.5% | CN¥17.50 | CN¥9.86 | CN¥8.57 | 12 |
Jul ’23 | CN¥10.29 | CN¥14.22 +38.1% | 14.2% | CN¥17.50 | CN¥9.86 | CN¥8.00 | 11 |
Jun ’23 | CN¥10.93 | CN¥13.51 +23.6% | 13.5% | CN¥15.67 | CN¥9.86 | CN¥8.46 | 12 |
May ’23 | CN¥11.60 | CN¥13.29 +14.6% | 13.8% | CN¥15.67 | CN¥9.86 | CN¥9.42 | 12 |
Apr ’23 | CN¥10.98 | CN¥12.03 +9.6% | 15.8% | CN¥14.48 | CN¥8.64 | CN¥8.96 | 11 |
Analysten-Prognose: Das Kursziel liegt weniger als 20% über dem aktuellen Aktienkurs.